Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000104.xml
Zentralbl Chir 2021; 146(04): 367-370
DOI: 10.1055/a-1209-6009
DOI: 10.1055/a-1209-6009
Aktuelle Chirurgie
Patient Blood Management in der Chirurgie
Chirurgische Eingriffe sind oftmals mit einem hohen Blutverlust assoziiert, der zu einer erhöhten postoperativen Komplikationsrate führen kann. Patient Blood Management (PBM) ist ein evidenzbasiertes multimodales Konzept, welches unter Berücksichtigung modernster medizinischer Erkenntnisse zur Steigerung der Patientensicherheit eingesetzt wird.
Publication History
Article published online:
24 August 2021
© 2021. Thieme. All rights reserved.
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
Literatur
- 1 Meybohm P, Richards T, Isbister J. et al. Patient Blood Management Maßnahmenbündel. Anästh Intensivmed 2017; 58: 14
- 2 Meybohm P, Herrmann E, Steinbicker AU. et al. PBM-study Collaborators. Patient Blood Management is Associated With a Substantial Reduction of Red Blood Cell Utilization and Safe for Patientʼs Outcome: A Prospective, Multicenter Cohort Study With a Noninferiority Design. Ann Surg 2016; 264: 203-211
- 3 Althoff FC, Neb H, Herrmann E. et al. Multimodal Patient Blood Management Program Based on a Three-pillar Strategy: A Systematic Review and Meta-analysis. Ann Surg 2019; 269: 794-804
- 4 Triphaus C, Judd L, Glaser P. et al. Effectiveness of Preoperative Iron Supplementation in Major Surgical Patients with Iron Deficiency: A Prospective Observational Study. Ann Surg 2019; DOI: 10.1097/SLA.0000000000003643.
- 5 Meybohm P, Choorapoikayil S, Wessels A. et al. Washed cell salvage in surgical patients: A review and meta-analysis of prospective randomized trials under PRISMA. Medicine 2016; 95: e4490
- 6 Sebastian M, Kiewe P, Schuette W. et al. Treatment of malignant pleural effusion with the trifunctional antibody catumaxomab (Removab) (anti-EpCAM x Anti-CD3): results of a phase 1/2 study. J Immunother 2009; 32: 195-202
- 7 Bundesärztekammer. Querschnitts-Leitlinien zur Therapie mit Blutkomponenten und Plasmaderivaten Gesamtnovelle 2020. Im Internet (Stand: 01.03.2021): https://www.bundesaerztekammer.de/fileadmin/user_upload/downloads/pdf-Ordner/MuE/Querschnitts-Leitlinien__BAEK__zur_Therapie_mit_Blutkomponenten_und_Plasmaderivaten_-_Gesamtnovelle_2020.pdf
- 8 Ker K, Edwards P, Perel P. et al. Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis. BMJ 2012; 344: e3054
- 9 Franchini M, Mengoli C, Marietta M. et al. Safety of intravenous tranexamic acid in patients undergoing majororthopaedic surgery: a meta-analysis of randomised controlled trials. Blood Transfus 2018; 16: 36-43
- 10 Taeuber I, Weibel S, Herrmann E. et al. Does Intravenous Tranexamic Acid Increase the Probability for Thromboembolic Events? A Systematic Review, Meta-Analysis and Meta-Regression of Prospective Randomized Trials. JAMA Surg 2021; DOI: 10.1001/jamasurg.2021.0884.
- 11 Meybohm P, Muellenbach RM, Keller H. et al. Patient Blood Management in der Herzchirurgie. Z Herz-Thorax-Gefäßchir 2017; 31: 247-265
- 12 Yang WW, Thakkar RN, Gehrie EA. et al. Single-unit transfusions and hemoglobin trigger: relative impact on red cell utilization. Transfusion 2017; 57: 1163-1170